Skip to main navigation
Skip to search
Skip to main content
The University of Brighton Home
Home
Profiles
Research units
Equipment
Projects
Research output
Activities
Student theses
Search by expertise, name or affiliation
Serine proteases in bone disease
Nadia Bouteldja, David J. Timson
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Serine proteases in bone disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Serine Protease
100%
Bone Disease
100%
Bone Tissue
66%
Signaling Molecules
33%
Physiological Processes
33%
Matrix Metalloproteases
33%
Arthritis
33%
Cartilage
33%
Disease Process
33%
Systemic Effects
33%
Effective Treatment
33%
Serine Protease Inhibitor
33%
Strong Connections
33%
Extracellular Matrix Protein 1 (ECM1)
33%
Overall Effect
33%
Multiple Pathways
33%
Tissue Inflammation
33%
Arthropathy
33%
Proteolysis
33%
Protease-activated Receptor 1 (PAR1)
33%
Molecular Disorder
33%
Transforming Growth Factor-β
33%
Pathological Process
33%
Bone Invasion
33%
Growth Factor Binding
33%
Tissue Destruction
33%
Metastatic Bone
33%
Medicine and Dentistry
Serine Proteinase
100%
Bone Disease
100%
Bone Tissue
66%
Arthritis
33%
Arthropathy
33%
Disease Process
33%
Scleroprotein
33%
Proteinase Activated Receptor
33%
Pathological Process
33%
Serine Proteinase Inhibitor
33%
Signaling Molecule
33%
Protein Degradation
33%
Molecular Disease
33%
Bone Metastasis
33%
Cancer Growth Factor
33%
Pharmacology, Toxicology and Pharmaceutical Science
Serine Proteinase
100%
Bone Disease
100%
Inflammation
33%
Arthritis
33%
Serine Proteinase Inhibitor
33%
Arthropathy
33%
Proteinase Activated Receptor
33%
Bone Metastasis
33%
Scleroprotein
33%
Cancer Growth Factor
33%
Diseases
33%
Biochemistry, Genetics and Molecular Biology
Serine Protease
100%
Enzyme
33%
Serine Protease Inhibitor
33%
Agonist
33%
Extracellular Matrix Proteins
33%
Scleroprotein
33%
Protease-Activated Receptor
33%
Molecular Disease
33%
Cancer Growth Factor
33%
Proteolysis
33%